Heparin therapy for deep vein thrombosis: From hospital to home

American Journal of Medicine

Volumn 110, Issue 6, 2001, Pages 501-502

  Kearon, Clive ^a   Gent, Michael ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

DEEP VEIN THROMBOSIS; EDITORIAL; HEPARINIZATION; HOME CARE; HUMAN; OUTPATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; SELF INJECTION; TREATMENT OUTCOME;

AMBULATORY CARE; ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; VENOUS THROMBOSIS;

EID: 0035870791     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00687-8     Document Type: Editorial

References (15)

1. Gallus A.S., Jackaman J., Tillett J., et al. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet. 2:1986;1293-1296.
2. Hull R., Raskob G., Rosenbloom D., et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 322:1990;1260-1264.
3. Weitz J. Low-molecular-weight heparins. N Engl J Med. 337:1997;688-698.
4. Levine M., Gent M., Hirsh J., et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 334:1996;677-681.
5. Koopman M.M.W., Prandoni P., Piovella F., et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 334:1996;682-687.
6. Lensing A.W.A., Prins M.H., Davidson B.L., Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. Arch Intern Med. 155:1995;601-607.
7. Dolovich L.R., Ginsberg J.S., Douketis J.D., et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism examining some unanswered questions regarding location of treatment, product type, and dosing frequency . Arch Intern Med. 160:2000;181-188.
8. Gould M.K., Dembitzer A.D., Doyle R.L., et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized controlled trials. Ann Intern Med. 130:1999;800-809.
9. Gould M.K., Dembitzer A.D., Sanders G.D., Garber A.M. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med. 130:1999;789-799.
10. O'Brien B., Levine M., Willan A., et al. Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis. Arch Intern Med. 159:1999;2298-2304.
11. Harrison L., McGinnis J., Crowther M., et al. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med. 158:1998;2001-2003.
12. Wells P.S., Kovacs M.J., Bormanis J., et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch Intern Med. 158:1998;1809-1812.
13. Dunn AS, et al. Outpatient treatment of deep vein thrombosis. Am J Med. 2001;110:458-462.
14. Dunn A.S., Coller B. Outpatient treatment of deep vein thrombosis translating clinical trials into practice . Am J Med. 106:1999;660-669.
15. Fried T.R., van Doorn C., O'Leary J.R., et al. Older persons' perceptions of home and hospital as sites of treatment for acute illness. Am J Med. 107:1999;317-323.